Eli Lilly in Talks to Buy Next-Gen CAR-T Biotech Kelonia for More Than $2 Billion

Eli Lilly plans to buy Kelonia Therapeutics for $2B+. The deal would boost Lilly’s cancer business and reduce reliance on weight-loss drugs.